Chlozepide filmcoated tablets 0,005 g
Chlozepide filmcoated tablets 0,005 g Uses, Dosage, Side Effects, Food Interaction and all others data.
An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
Chlozepide filmcoated tablets 0,005 g has antianxiety, sedative, appetite-stimulating and weak analgesic actions. The drug seems to block EEG arousal from stimulation in the brain stem reticular formation. The drug has been studied extensively in many species of animals and these studies are suggestive of action on the limbic system of the brain, which recent evidence indicates is involved in emotional responses. Hostile monkeys were made tame by oral drug doses which did not cause sedation. Chlozepide filmcoated tablets 0,005 g revealed a "taming" action with the elimination of fear and aggression. The taming effect of chlordiazepoxide was further demonstrated in rats made vicious by lesions in the septal area of the brain. The drug dosage which effectively blocked the vicious reaction was well below the dose which caused sedation in these animals.
| Trade Name | Chlozepide filmcoated tablets 0,005 g |
| Availability | Prescription only |
| Generic | Chlordiazepoxide |
| Chlordiazepoxide Other Names | Chloradiazepoxide, Chlordiazepoxide, Chlordiazepoxidum, Clopoxide, Clordiazepóxido, Methaminodiazepoxide |
| Related Drugs | escitalopram, alprazolam, duloxetine, Lexapro, Xanax, diazepam, atenolol, Cymbalta, promethazine, Valium |
| Type | |
| Formula | C16H14ClN3O |
| Weight | Average: 299.755 Monoisotopic: 299.082539792 |
| Groups | Approved, Illicit, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Russia |
| Last Updated: | September 19, 2023 at 7:00 am |
Uses
Chlozepide filmcoated tablets 0,005 g is a benzodiazepine used to treat the withdrawal symptoms of acute alcoholism, to treat preoperative anxiety, and to treat anxiety over a short term period.
For the management of anxiety disorders or for the short-term relief of symptoms of anxiety, withdrawal symptoms of acute alcoholism, and preoperative apprehension and anxiety.
Chlozepide filmcoated tablets 0,005 g is also used to associated treatment for these conditions: Alcohol Withdrawal Syndrome, Anxiety, Anxiety Disorders, Depression, Peptic Ulcer Disease, Acute Anxiety, Pyschosomatic disease
How Chlozepide filmcoated tablets 0,005 g works
Chlozepide filmcoated tablets 0,005 g binds to stereospecific benzodiazepine (BZD) binding sites on GABA (A) receptor complexes at several sites within the central nervous system, including the limbic system and reticular formation. This results in an increased binding of the inhibitory neurotransmitter GABA to the GABA(A) receptor. BZDs, therefore, enhance GABA-mediated chloride influx through GABA receptor channels, causing membrane hyperpolarization. The net neuro-inhibitory effects result in the observed sedative, hypnotic, anxiolytic, and muscle relaxant properties.
Toxicity
LD50=537 mg/kg (Orally in rats). Signs of overdose include respiratory depression, muscle weakness, somnolence (general depressed activity).
Food Interaction
- Avoid alcohol.
- Take with or without food. The absorption is unaffected by food.
[Moderate] GENERALLY AVOID: Alcohol may potentiate some of the pharmacologic effects of CNS-active agents.
Use in combination may result in additive central nervous system depression and
MANAGEMENT: Patients receiving CNS-active agents should be warned of this interaction and advised to avoid or limit consumption of alcohol.
Ambulatory patients should be counseled to avoid hazardous activities requiring complete mental alertness and motor coordination until they know how these agents affect them, and to notify their physician if they experience excessive or prolonged CNS effects that interfere with their normal activities.
Chlozepide filmcoated tablets 0,005 g Drug Interaction
Moderate: pregabalin, pregabalin, metoprolol, metoprolol, metoprolol, metoprolol, hydroxyzine, hydroxyzine, alprazolam, alprazolamUnknown: omega-3 polyunsaturated fatty acids, omega-3 polyunsaturated fatty acids, atorvastatin, atorvastatin, meloxicam, meloxicam, cyanocobalamin, cyanocobalamin, cholecalciferol, cholecalciferol
Chlozepide filmcoated tablets 0,005 g Disease Interaction
Major: acute alcohol intoxication, closed-angle glaucoma, drug dependence, renal/liver disease, respiratory depression, seizures, prolonged hypotensionModerate: depression, obesity, paradoxical reactions, porphyria
Half Life
24-48 hours
Elimination Route
Chlozepide filmcoated tablets 0,005 g is excreted in the urine, with 1% to 2% unchanged and 3% to 6% as conjugate.
Innovators Monograph
You find simplified version here Chlozepide filmcoated tablets 0,005 g
